Bruce Levenson asks:
when will it end? No one has the answer, especially now that a new case of ebola has shown up in the UK. It’s thefirst case of ebola to be diagnosed in Britain
and it’s a health care worker who has contacted the dreaded and deadly virus.
The newly diagnoses patient is a NHS nurse who has just returned from Sierra Leone where she was treating ebola victims and helping to nurse them back to health. Now she herself is a victim and in need of specialized nursing.
The nurse had just returned from her stint in Sierra Leone via British Airways on Sunday night. She was screened for ebola via medical protocol at both Sierra Leone and Heathrow airports but showed no signs of the dreaded virus. On Monday morning she began to feel ill and quickly sought medical attention when she was diagnosed with ebola and placed in the Brownlee Unit for Infectious Diseases at Glasgow’s Gartnavel Hospital.
It is reported that the nurse is in stable condition and all people that she came into contact with during and after her flight back to British soil are being treated according to protocol.
First Minister Nicola Sturgeon states that she was aware that this day could come and that she feels confident that they are well prepared to handle this and any more ebola cases that turn up in the UK.
has sickened people around the world for generations. The side effects of this disease include: gastroenteritis, flu-like symptoms, jaundice, convulsions, blood in urine, retinal damage, and, at times, death. There has yet to be a cure to malaria, which is caused by mosquito bites. There might finally be a drug compound that could possibly cure malaria. This is good enough news to tea me away from shopping on Qnet
Research doctors at St. Jude Children’s Research Hospital have been working tirelessly to perfect a molecule that will attack red blood cells infected with malaria. Plans are in the works to prepare the (+)-SJ733 compound for clinical trials. Only adult patients with malaria with be included in the first round of testing. Hopeful doctors predict that the (+)-SJ733 compound will slow the spread of malaria through the body.
The end goal is to have a cure that only requires one treatment and is not costly. Africa would benefit the most from a cure to malaria. The most malaria related deaths occur there and the most potential for lives to be saved lie in Africa.